| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TAGAP TBC1D3I TBC1D3G TBC1D3C TBC1D3B ANKRD27 TBC1D3K TBC1D3F | 3.42e-11 | 279 | 75 | 13 | GO:0005096 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D RASGRF1 TAGAP RIMS1 TBC1D3I TBC1D3G TBC1D3C TBC1D3B ANKRD27 TBC1D3K TBC1D3F SOS2 | 5.08e-11 | 507 | 75 | 16 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D RASGRF1 TAGAP RIMS1 TBC1D3I TBC1D3G TBC1D3C TBC1D3B ANKRD27 TBC1D3K TBC1D3F SOS2 | 5.08e-11 | 507 | 75 | 16 | GO:0030695 |
| GeneOntologyMolecularFunction | enzyme activator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TAGAP XRCC5 TBC1D3I TBC1D3G TBC1D3C TBC1D3B ANKRD27 TBC1D3K TBC1D3F | 1.31e-07 | 656 | 75 | 14 | GO:0008047 |
| GeneOntologyMolecularFunction | calmodulin binding | 2.38e-06 | 230 | 75 | 8 | GO:0005516 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D RASGRF1 TAGAP NAP1L2 RIMS1 XRCC5 TBC1D3I TBC1D3G TBC1D3C TBC1D3B ANKRD27 TBC1D3K TBC1D3F SOS2 | 3.69e-06 | 1418 | 75 | 18 | GO:0030234 |
| GeneOntologyMolecularFunction | calcium channel activity | 9.04e-06 | 129 | 75 | 6 | GO:0005262 | |
| GeneOntologyMolecularFunction | phorbol ester receptor activity | 1.39e-05 | 2 | 75 | 2 | GO:0001565 | |
| GeneOntologyMolecularFunction | non-kinase phorbol ester receptor activity | 1.39e-05 | 2 | 75 | 2 | GO:0001566 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.80e-05 | 14 | 75 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.22e-05 | 151 | 75 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 2.66e-05 | 46 | 75 | 4 | GO:0005245 | |
| GeneOntologyMolecularFunction | diacylglycerol binding | 2.75e-05 | 16 | 75 | 3 | GO:0019992 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 3.99e-05 | 18 | 75 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 4.33e-05 | 343 | 75 | 8 | GO:0005261 | |
| GeneOntologyMolecularFunction | molecular function activator activity | CACNA1S TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TAGAP XRCC5 TBC1D3I TBC1D3G TBC1D3C TBC1D3B ANKRD27 TBC1D3K TBC1D3F | 4.54e-05 | 1233 | 75 | 15 | GO:0140677 |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 8.31e-05 | 4 | 75 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | syntaxin-1 binding | 9.73e-05 | 24 | 75 | 3 | GO:0017075 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 1.38e-04 | 5 | 75 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | SNARE binding | 1.60e-04 | 136 | 75 | 5 | GO:0000149 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 2.07e-04 | 6 | 75 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 2.12e-04 | 31 | 75 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 2.56e-04 | 33 | 75 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | gated channel activity | 2.58e-04 | 334 | 75 | 7 | GO:0022836 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 2.69e-04 | 152 | 75 | 5 | GO:0022843 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 3.21e-04 | 459 | 75 | 8 | GO:0005216 | |
| GeneOntologyMolecularFunction | syntaxin binding | 3.23e-04 | 87 | 75 | 4 | GO:0019905 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 3.51e-04 | 465 | 75 | 8 | GO:0046873 | |
| GeneOntologyMolecularFunction | 5'-deoxyribose-5-phosphate lyase activity | 3.84e-04 | 8 | 75 | 2 | GO:0051575 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 5.55e-04 | 627 | 75 | 9 | GO:0022890 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 6.13e-04 | 182 | 75 | 5 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 6.45e-04 | 184 | 75 | 5 | GO:0022832 | |
| GeneOntologyMolecularFunction | channel activity | 7.79e-04 | 525 | 75 | 8 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 7.89e-04 | 526 | 75 | 8 | GO:0022803 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 8.35e-04 | 664 | 75 | 9 | GO:0008324 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 2.09e-03 | 758 | 75 | 9 | GO:0015318 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 2.83e-03 | 793 | 75 | 9 | GO:0015075 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 3.90e-03 | 84 | 75 | 3 | GO:0003684 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 5.39e-03 | 875 | 75 | 9 | GO:0019904 | |
| GeneOntologyMolecularFunction | alpha-actinin binding | 6.03e-03 | 31 | 75 | 2 | GO:0051393 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 8.20e-03 | 614 | 75 | 7 | GO:0140657 | |
| GeneOntologyMolecularFunction | transporter activity | CYC1 CACNA1C CACNA1D CACNA1S TRPA1 STARD4 SCN8A KCNAB1 ABCA9 RYR2 RYR3 | 8.44e-03 | 1289 | 75 | 11 | GO:0005215 |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D RASGRF1 TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 5.04e-15 | 109 | 75 | 12 | GO:0090630 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D RASGRF1 TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 7.75e-11 | 244 | 75 | 12 | GO:0043547 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D RASGRF1 PAFAH1B1 TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.22e-10 | 335 | 75 | 13 | GO:0043087 |
| GeneOntologyBiologicalProcess | presynaptic dense core vesicle exocytosis | 3.33e-08 | 10 | 75 | 4 | GO:0099525 | |
| GeneOntologyBiologicalProcess | neuronal dense core vesicle exocytosis | 7.81e-08 | 12 | 75 | 4 | GO:0099011 | |
| GeneOntologyBiologicalProcess | dense core granule priming | 1.84e-07 | 4 | 75 | 3 | GO:0061789 | |
| GeneOntologyBiologicalProcess | dense core granule exocytosis | 2.13e-07 | 15 | 75 | 4 | GO:1990504 | |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D RASGRF1 TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.31e-07 | 499 | 75 | 12 | GO:0051345 |
| GeneOntologyBiologicalProcess | synaptic vesicle docking | 3.70e-07 | 17 | 75 | 4 | GO:0016081 | |
| GeneOntologyBiologicalProcess | organelle localization by membrane tethering | 6.57e-07 | 85 | 75 | 6 | GO:0140056 | |
| GeneOntologyBiologicalProcess | membrane docking | 9.84e-07 | 91 | 75 | 6 | GO:0022406 | |
| GeneOntologyBiologicalProcess | calcium ion-regulated exocytosis of neurotransmitter | 1.92e-06 | 25 | 75 | 4 | GO:0048791 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | CACNA1C CACNA1D TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D RASGRF1 HIPK1 XRCC5 TBC1D3I IL1RAP TBC1D3G TBC1D3C TBC1D3B RYR2 TBC1D3K TBC1D3F | 2.63e-06 | 1430 | 75 | 18 | GO:0044093 |
| GeneOntologyBiologicalProcess | dense core granule localization | 3.09e-06 | 28 | 75 | 4 | GO:0032253 | |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | CACNA1C CACNA1D TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D RASGRF1 XRCC5 TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 3.60e-06 | 1028 | 75 | 15 | GO:0043085 |
| GeneOntologyBiologicalProcess | synaptic vesicle priming | 4.71e-06 | 31 | 75 | 4 | GO:0016082 | |
| GeneOntologyBiologicalProcess | secretory granule localization | 6.88e-06 | 34 | 75 | 4 | GO:0032252 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 7.46e-06 | 11 | 75 | 3 | GO:0071313 | |
| GeneOntologyBiologicalProcess | calcium-ion regulated exocytosis | 1.22e-05 | 82 | 75 | 5 | GO:0017156 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle priming | 1.30e-05 | 2 | 75 | 2 | GO:0010808 | |
| GeneOntologyBiologicalProcess | dense core granule docking | 1.30e-05 | 2 | 75 | 2 | GO:0061790 | |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D RASGRF1 PAFAH1B1 TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.51e-05 | 878 | 75 | 13 | GO:0051336 |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle priming | 1.63e-05 | 14 | 75 | 3 | GO:0010807 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 1.63e-05 | 14 | 75 | 3 | GO:0071415 | |
| GeneOntologyBiologicalProcess | vesicle docking involved in exocytosis | 1.96e-05 | 44 | 75 | 4 | GO:0006904 | |
| GeneOntologyBiologicalProcess | response to caffeine | 5.86e-05 | 21 | 75 | 3 | GO:0031000 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 7.67e-05 | 62 | 75 | 4 | GO:0086002 | |
| GeneOntologyBiologicalProcess | vesicle docking | 9.23e-05 | 65 | 75 | 4 | GO:0048278 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 1.30e-04 | 5 | 75 | 2 | GO:1904879 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 1.39e-04 | 217 | 75 | 6 | GO:0097553 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 1.39e-04 | 217 | 75 | 6 | GO:0006941 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic plasticity | 1.94e-04 | 6 | 75 | 2 | GO:0031914 | |
| GeneOntologyBiologicalProcess | regulation of neuronal synaptic plasticity | 2.38e-04 | 83 | 75 | 4 | GO:0048168 | |
| GeneOntologyBiologicalProcess | cell-cell signaling involved in cardiac conduction | 2.55e-04 | 34 | 75 | 3 | GO:0086019 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 2.86e-04 | 87 | 75 | 4 | GO:0086001 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 3.02e-04 | 36 | 75 | 3 | GO:0086010 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 3.28e-04 | 37 | 75 | 3 | GO:0014808 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 3.69e-04 | 93 | 75 | 4 | GO:0086003 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 3.84e-04 | 39 | 75 | 3 | GO:1903514 | |
| GeneOntologyBiologicalProcess | cellular response to alkaloid | 4.14e-04 | 40 | 75 | 3 | GO:0071312 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 5.49e-04 | 44 | 75 | 3 | GO:0070296 | |
| GeneOntologyBiologicalProcess | establishment of centrosome localization | 5.76e-04 | 10 | 75 | 2 | GO:0051660 | |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell signaling | 5.76e-04 | 10 | 75 | 2 | GO:0086018 | |
| GeneOntologyBiologicalProcess | SA node cell action potential | 5.76e-04 | 10 | 75 | 2 | GO:0086015 | |
| GeneOntologyBiologicalProcess | positive regulation of inhibitory postsynaptic potential | 5.76e-04 | 10 | 75 | 2 | GO:0097151 | |
| GeneOntologyBiologicalProcess | acrosomal vesicle exocytosis | 5.76e-04 | 10 | 75 | 2 | GO:0060478 | |
| GeneOntologyBiologicalProcess | muscle contraction | 6.25e-04 | 400 | 75 | 7 | GO:0006936 | |
| GeneOntologyBiologicalProcess | exocytic process | 6.27e-04 | 107 | 75 | 4 | GO:0140029 | |
| GeneOntologyBiologicalProcess | ribosomal small subunit biogenesis | 6.49e-04 | 108 | 75 | 4 | GO:0042274 | |
| GeneOntologyBiologicalProcess | acrosome reaction | 6.67e-04 | 47 | 75 | 3 | GO:0007340 | |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell communication | 7.02e-04 | 11 | 75 | 2 | GO:0086070 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 7.10e-04 | 48 | 75 | 3 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 7.10e-04 | 48 | 75 | 3 | GO:1902656 | |
| GeneOntologyBiologicalProcess | action potential | 8.30e-04 | 201 | 75 | 5 | GO:0001508 | |
| GeneOntologyBiologicalProcess | modulation of inhibitory postsynaptic potential | 8.41e-04 | 12 | 75 | 2 | GO:0098828 | |
| GeneOntologyBiologicalProcess | spontaneous neurotransmitter secretion | 8.41e-04 | 12 | 75 | 2 | GO:0061669 | |
| GeneOntologyBiologicalProcess | regulation of ventricular cardiac muscle cell action potential | 8.41e-04 | 12 | 75 | 2 | GO:0098911 | |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell signaling | 8.41e-04 | 12 | 75 | 2 | GO:0086027 | |
| GeneOntologyBiologicalProcess | AV node cell action potential | 8.41e-04 | 12 | 75 | 2 | GO:0086016 | |
| GeneOntologyBiologicalProcess | urinary bladder smooth muscle contraction | 8.41e-04 | 12 | 75 | 2 | GO:0014832 | |
| GeneOntologyBiologicalProcess | organelle localization | 9.94e-04 | 703 | 75 | 9 | GO:0051640 | |
| GeneOntologyBiologicalProcess | synaptic vesicle exocytosis | 1.12e-03 | 125 | 75 | 4 | GO:0016079 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 1.19e-03 | 127 | 75 | 4 | GO:0070252 | |
| GeneOntologyBiologicalProcess | cell communication involved in cardiac conduction | 1.30e-03 | 59 | 75 | 3 | GO:0086065 | |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell communication | 1.33e-03 | 15 | 75 | 2 | GO:0086067 | |
| GeneOntologyBiologicalProcess | urinary tract smooth muscle contraction | 1.33e-03 | 15 | 75 | 2 | GO:0014848 | |
| GeneOntologyBiologicalProcess | establishment of vesicle localization | 1.35e-03 | 224 | 75 | 5 | GO:0051650 | |
| GeneOntologyBiologicalProcess | positive regulation of membrane depolarization | 1.51e-03 | 16 | 75 | 2 | GO:1904181 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CYC1 CACNA1C CACNA1D CACNA1S TRPA1 ALG10 SCN8A KCNAB1 RYR2 RYR3 | 1.80e-03 | 922 | 75 | 10 | GO:0098662 |
| GeneOntologyBiologicalProcess | spontaneous synaptic transmission | 1.92e-03 | 18 | 75 | 2 | GO:0098814 | |
| GeneOntologyBiologicalProcess | neuromuscular junction development | 1.95e-03 | 68 | 75 | 3 | GO:0007528 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 1.96e-03 | 359 | 75 | 6 | GO:0006874 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 1.98e-03 | 146 | 75 | 4 | GO:0051209 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 2.03e-03 | 147 | 75 | 4 | GO:0051283 | |
| GeneOntologyBiologicalProcess | vesicle localization | 2.06e-03 | 247 | 75 | 5 | GO:0051648 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CYC1 CACNA1C CACNA1D CACNA1S TRPA1 ALG10 SCN8A KCNAB1 RYR2 RYR3 | 2.11e-03 | 942 | 75 | 10 | GO:0098655 |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 2.14e-03 | 149 | 75 | 4 | GO:0051282 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle cell to AV node cell communication | 2.14e-03 | 19 | 75 | 2 | GO:0086066 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle cell to AV node cell signaling | 2.14e-03 | 19 | 75 | 2 | GO:0086026 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle cell action potential | 2.14e-03 | 19 | 75 | 2 | GO:0086014 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 2.35e-03 | 153 | 75 | 4 | GO:0051208 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 2.35e-03 | 153 | 75 | 4 | GO:0030048 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 1.28e-06 | 23 | 75 | 4 | GO:0098831 | |
| GeneOntologyCellularComponent | calcium channel complex | 6.45e-06 | 73 | 75 | 5 | GO:0034704 | |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 9.53e-06 | 12 | 75 | 3 | GO:1990454 | |
| GeneOntologyCellularComponent | presynaptic active zone | 1.16e-05 | 141 | 75 | 6 | GO:0048786 | |
| GeneOntologyCellularComponent | cell cortex region | 2.04e-05 | 45 | 75 | 4 | GO:0099738 | |
| GeneOntologyCellularComponent | cation channel complex | 2.15e-05 | 235 | 75 | 7 | GO:0034703 | |
| GeneOntologyCellularComponent | I band | 2.93e-05 | 166 | 75 | 6 | GO:0031674 | |
| GeneOntologyCellularComponent | preribosome | 5.62e-05 | 114 | 75 | 5 | GO:0030684 | |
| GeneOntologyCellularComponent | presynaptic membrane | 6.12e-05 | 277 | 75 | 7 | GO:0042734 | |
| GeneOntologyCellularComponent | Z disc | 2.11e-04 | 151 | 75 | 5 | GO:0030018 | |
| GeneOntologyCellularComponent | sarcomere | 2.73e-04 | 249 | 75 | 6 | GO:0030017 | |
| GeneOntologyCellularComponent | calyx of Held | 2.91e-04 | 36 | 75 | 3 | GO:0044305 | |
| GeneOntologyCellularComponent | terminal bouton | 3.96e-04 | 96 | 75 | 4 | GO:0043195 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 4.13e-04 | 378 | 75 | 7 | GO:0034702 | |
| GeneOntologyCellularComponent | myofibril | 4.45e-04 | 273 | 75 | 6 | GO:0030016 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 5.64e-04 | 523 | 75 | 8 | GO:1902495 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 6.03e-04 | 46 | 75 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | sarcolemma | 6.07e-04 | 190 | 75 | 5 | GO:0042383 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 6.11e-04 | 290 | 75 | 6 | GO:0043292 | |
| GeneOntologyCellularComponent | transporter complex | 7.84e-04 | 550 | 75 | 8 | GO:1990351 | |
| GeneOntologyCellularComponent | axon | UNC13B CACNA1C TRPA1 RASGRF1 POLG PAFAH1B1 SCN8A KCNAB1 UNC13C UNC13A | 1.27e-03 | 891 | 75 | 10 | GO:0030424 |
| GeneOntologyCellularComponent | preribosome, small subunit precursor | 1.29e-03 | 15 | 75 | 2 | GO:0030688 | |
| GeneOntologyCellularComponent | cytoplasmic region | 1.86e-03 | 360 | 75 | 6 | GO:0099568 | |
| GeneOntologyCellularComponent | small-subunit processome | 2.58e-03 | 76 | 75 | 3 | GO:0032040 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 2.78e-03 | 78 | 75 | 3 | GO:0048787 | |
| GeneOntologyCellularComponent | T-tubule | 2.88e-03 | 79 | 75 | 3 | GO:0030315 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 3.91e-03 | 88 | 75 | 3 | GO:0016529 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 4.43e-03 | 185 | 75 | 4 | GO:0009898 | |
| GeneOntologyCellularComponent | distal axon | 4.71e-03 | 435 | 75 | 6 | GO:0150034 | |
| GeneOntologyCellularComponent | synaptic membrane | 4.89e-03 | 583 | 75 | 7 | GO:0097060 | |
| Domain | TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 3.19e-15 | 49 | 73 | 10 | SM00164 |
| Domain | RabGAP-TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 7.48e-15 | 53 | 73 | 10 | PF00566 |
| Domain | TBC_RABGAP | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.11e-14 | 55 | 73 | 10 | PS50086 |
| Domain | Rab-GTPase-TBC_dom | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.11e-14 | 55 | 73 | 10 | IPR000195 |
| Domain | Unc-13 | 5.73e-08 | 3 | 73 | 3 | IPR027080 | |
| Domain | VDCC_L_a1su | 2.29e-07 | 4 | 73 | 3 | IPR005446 | |
| Domain | Ion_trans_dom | 3.06e-07 | 114 | 73 | 7 | IPR005821 | |
| Domain | Ion_trans | 3.06e-07 | 114 | 73 | 7 | PF00520 | |
| Domain | Munc13_dom-2 | 5.70e-07 | 5 | 73 | 3 | IPR014772 | |
| Domain | Membr_traf_MHD | 5.70e-07 | 5 | 73 | 3 | PF10540 | |
| Domain | MHD2 | 5.70e-07 | 5 | 73 | 3 | PS51259 | |
| Domain | Munc13_subgr_dom-2 | 5.70e-07 | 5 | 73 | 3 | IPR019558 | |
| Domain | DUF1041 | 5.70e-07 | 5 | 73 | 3 | SM01145 | |
| Domain | DUF1041 | 1.98e-06 | 7 | 73 | 3 | PF06292 | |
| Domain | Munc13_1 | 1.98e-06 | 7 | 73 | 3 | IPR014770 | |
| Domain | VDCC_a1su_IQ | 1.98e-06 | 7 | 73 | 3 | IPR014873 | |
| Domain | GPHH | 1.98e-06 | 7 | 73 | 3 | PF16905 | |
| Domain | CAPS_dom | 1.98e-06 | 7 | 73 | 3 | IPR010439 | |
| Domain | MHD1 | 1.98e-06 | 7 | 73 | 3 | PS51258 | |
| Domain | GPHH_dom | 1.98e-06 | 7 | 73 | 3 | IPR031649 | |
| Domain | Ca_chan_IQ | 1.98e-06 | 7 | 73 | 3 | SM01062 | |
| Domain | Ca_chan_IQ | 1.98e-06 | 7 | 73 | 3 | PF08763 | |
| Domain | C2_dom | 3.55e-06 | 164 | 73 | 7 | IPR000008 | |
| Domain | VDCCAlpha1 | 6.74e-06 | 10 | 73 | 3 | IPR002077 | |
| Domain | C2 | 1.23e-05 | 131 | 73 | 6 | PF00168 | |
| Domain | C2 | 1.59e-05 | 137 | 73 | 6 | SM00239 | |
| Domain | C2 | 1.95e-05 | 142 | 73 | 6 | PS50004 | |
| Domain | - | 2.46e-05 | 148 | 73 | 6 | 2.60.40.150 | |
| Domain | Ryanrecept_TM4-6 | 4.51e-05 | 3 | 73 | 2 | IPR009460 | |
| Domain | CAC1F_C | 4.51e-05 | 3 | 73 | 2 | IPR031688 | |
| Domain | RyR | 4.51e-05 | 3 | 73 | 2 | PF02026 | |
| Domain | CAC1F_C | 4.51e-05 | 3 | 73 | 2 | PF16885 | |
| Domain | Ryanodine_rcpt | 4.51e-05 | 3 | 73 | 2 | IPR003032 | |
| Domain | RR_TM4-6 | 4.51e-05 | 3 | 73 | 2 | PF06459 | |
| Domain | Ryan_recept | 4.51e-05 | 3 | 73 | 2 | IPR013333 | |
| Domain | Channel_four-helix_dom | 7.25e-05 | 57 | 73 | 4 | IPR027359 | |
| Domain | - | 7.25e-05 | 57 | 73 | 4 | 1.20.120.350 | |
| Domain | C1_1 | 7.25e-05 | 57 | 73 | 4 | PF00130 | |
| Domain | ZF_DAG_PE_1 | 1.14e-04 | 64 | 73 | 4 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 1.14e-04 | 64 | 73 | 4 | PS50081 | |
| Domain | C1 | 1.21e-04 | 65 | 73 | 4 | SM00109 | |
| Domain | PE/DAG-bd | 1.29e-04 | 66 | 73 | 4 | IPR002219 | |
| Domain | RIH_assoc | 2.24e-04 | 6 | 73 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 2.24e-04 | 6 | 73 | 2 | IPR013662 | |
| Domain | RIH_dom | 2.24e-04 | 6 | 73 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 2.24e-04 | 6 | 73 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 2.24e-04 | 6 | 73 | 2 | IPR015925 | |
| Domain | - | 2.24e-04 | 6 | 73 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 2.24e-04 | 6 | 73 | 2 | PF01365 | |
| Domain | Ins145_P3_rec | 2.24e-04 | 6 | 73 | 2 | PF08709 | |
| Domain | MIR | 6.64e-04 | 10 | 73 | 2 | PS50919 | |
| Domain | MIR | 6.64e-04 | 10 | 73 | 2 | PF02815 | |
| Domain | MIR | 6.64e-04 | 10 | 73 | 2 | SM00472 | |
| Domain | MIR_motif | 6.64e-04 | 10 | 73 | 2 | IPR016093 | |
| Domain | Ras_G-nucl-exch_fac_CS | 1.33e-03 | 14 | 73 | 2 | IPR019804 | |
| Domain | RasGEFN | 2.74e-03 | 20 | 73 | 2 | SM00229 | |
| Domain | RasGEF_N | 3.02e-03 | 21 | 73 | 2 | PF00618 | |
| Domain | Ras-like_Gua-exchang_fac_N | 3.31e-03 | 22 | 73 | 2 | IPR000651 | |
| Domain | RASGEF_NTER | 3.31e-03 | 22 | 73 | 2 | PS50212 | |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | TBC1D3E TBC1D3 TBC1D3H TBC1D3L AATF TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K | 1.46e-11 | 99 | 62 | 10 | M46448 |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.09e-07 | 11 | 62 | 4 | M47958 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 1.61e-06 | 6 | 62 | 3 | M47762 | |
| Pathway | KEGG_CARDIAC_MUSCLE_CONTRACTION | 2.45e-05 | 79 | 62 | 5 | M17673 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 2.85e-05 | 14 | 62 | 3 | M47692 | |
| Pathway | WP_SYNAPTIC_VESICLE_PATHWAY | 7.26e-05 | 51 | 62 | 4 | M39457 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 1.35e-04 | 23 | 62 | 3 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 1.74e-04 | 25 | 62 | 3 | M47948 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.62e-04 | 130 | 62 | 5 | M27454 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 3.10e-04 | 74 | 62 | 4 | M39462 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 3.10e-04 | 74 | 62 | 4 | M16376 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 3.10e-04 | 74 | 62 | 4 | MM15962 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 4.62e-04 | 147 | 62 | 5 | MM15854 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 4.81e-04 | 83 | 62 | 4 | M8728 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 5.22e-04 | 151 | 62 | 5 | M39329 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 6.53e-04 | 90 | 62 | 4 | M835 | |
| Pathway | KEGG_ALZHEIMERS_DISEASE | 8.03e-04 | 166 | 62 | 5 | M16024 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 8.23e-04 | 42 | 62 | 3 | M7169 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 1.01e-03 | 101 | 62 | 4 | M1979 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.10e-03 | 178 | 62 | 5 | M2890 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 1.44e-03 | 13 | 62 | 2 | M39589 | |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.54e-30 | 11 | 76 | 11 | 16863688 |
| Pubmed | An active vesicle priming machinery suppresses axon regeneration upon adult CNS injury. | 1.05e-10 | 5 | 76 | 4 | 34706221 | |
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | 2.87e-10 | 74 | 76 | 7 | 16625196 | |
| Pubmed | Munc13 supports fusogenicity of non-docked vesicles at synapses with disrupted active zones. | 7.33e-10 | 7 | 76 | 4 | 36398873 | |
| Pubmed | Molecular and functional architecture of striatal dopamine release sites. | 6.87e-09 | 11 | 76 | 4 | 34767769 | |
| Pubmed | 1.00e-08 | 3 | 76 | 3 | 17289261 | ||
| Pubmed | 1.00e-08 | 3 | 76 | 3 | 23658173 | ||
| Pubmed | 1.00e-08 | 3 | 76 | 3 | 17767505 | ||
| Pubmed | 1.00e-08 | 3 | 76 | 3 | 2173707 | ||
| Pubmed | 1.00e-08 | 3 | 76 | 3 | 33105896 | ||
| Pubmed | 1.00e-08 | 3 | 76 | 3 | 22966208 | ||
| Pubmed | 1.00e-08 | 3 | 76 | 3 | 15988013 | ||
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 4.00e-08 | 4 | 76 | 3 | 12359748 | |
| Pubmed | 4.00e-08 | 4 | 76 | 3 | 20937870 | ||
| Pubmed | 4.00e-08 | 4 | 76 | 3 | 8406013 | ||
| Pubmed | 1.00e-07 | 5 | 76 | 3 | 12604796 | ||
| Pubmed | 1.00e-07 | 5 | 76 | 3 | 8471161 | ||
| Pubmed | 1.00e-07 | 5 | 76 | 3 | 32755572 | ||
| Pubmed | 1.00e-07 | 5 | 76 | 3 | 22248876 | ||
| Pubmed | Disentangling the Roles of RIM and Munc13 in Synaptic Vesicle Localization and Neurotransmission. | 1.00e-07 | 5 | 76 | 3 | 33139401 | |
| Pubmed | 1.00e-07 | 5 | 76 | 3 | 31663850 | ||
| Pubmed | Identification of a Munc13-sensitive step in chromaffin cell large dense-core vesicle exocytosis. | 1.00e-07 | 5 | 76 | 3 | 26575293 | |
| Pubmed | Redundant functions of RIM1alpha and RIM2alpha in Ca(2+)-triggered neurotransmitter release. | 3.03e-07 | 26 | 76 | 4 | 17124501 | |
| Pubmed | 3.49e-07 | 7 | 76 | 3 | 12900400 | ||
| Pubmed | Unconventional molecular regulation of synaptic vesicle replenishment in cochlear inner hair cells. | 5.57e-07 | 8 | 76 | 3 | 25609709 | |
| Pubmed | 5.57e-07 | 8 | 76 | 3 | 11784029 | ||
| Pubmed | 6.33e-07 | 31 | 76 | 4 | 15217342 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 6.35e-07 | 139 | 76 | 6 | 16985003 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.47e-06 | 38 | 76 | 4 | 30786075 | |
| Pubmed | 2.17e-06 | 12 | 76 | 3 | 19095005 | ||
| Pubmed | 2.93e-06 | 45 | 76 | 4 | 25979088 | ||
| Pubmed | 4.48e-06 | 15 | 76 | 3 | 20188150 | ||
| Pubmed | 4.48e-06 | 15 | 76 | 3 | 24453333 | ||
| Pubmed | Maurocalcin and its analog MCaE12A facilitate Ca2+ mobilization in cardiomyocytes. | 4.71e-06 | 2 | 76 | 2 | 33034621 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 25277766 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 20014384 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 30001160 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 12070347 | ||
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 4.71e-06 | 2 | 76 | 2 | 21531043 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 21352396 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 12871971 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 1281468 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 16678258 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17561838 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 23070049 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 21054386 | ||
| Pubmed | Molecular nature of anomalous L-type calcium channels in mouse cerebellar granule cells. | 4.71e-06 | 2 | 76 | 2 | 17409250 | |
| Pubmed | Neuronal L-type calcium channels open quickly and are inhibited slowly. | 4.71e-06 | 2 | 76 | 2 | 16267232 | |
| Pubmed | Heterodimerization of Munc13 C2A domain with RIM regulates synaptic vesicle docking and priming. | 4.71e-06 | 2 | 76 | 2 | 28489077 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 24996399 | ||
| Pubmed | Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles. | 4.71e-06 | 2 | 76 | 2 | 10440375 | |
| Pubmed | Inhibition of exocytosis or endocytosis blocks activity-dependent redistribution of synapsin. | 4.71e-06 | 2 | 76 | 2 | 22066784 | |
| Pubmed | Munc13-1 is required for presynaptic long-term potentiation. | 4.71e-06 | 2 | 76 | 2 | 21849565 | |
| Pubmed | Ultrastructural Correlates of Presynaptic Functional Heterogeneity in Hippocampal Synapses. | 4.71e-06 | 2 | 76 | 2 | 32187536 | |
| Pubmed | Molecular Mechanisms of Synaptic Vesicle Priming by Munc13 and Munc18. | 4.71e-06 | 2 | 76 | 2 | 28772123 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 11576544 | ||
| Pubmed | Munc13-1 C1 domain activation lowers the energy barrier for synaptic vesicle fusion. | 4.71e-06 | 2 | 76 | 2 | 17267576 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 22814762 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 8898078 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 24086669 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 24849370 | ||
| Pubmed | Formation and Maintenance of Functional Spines in the Absence of Presynaptic Glutamate Release. | 4.71e-06 | 2 | 76 | 2 | 28426965 | |
| Pubmed | RIM1alpha forms a protein scaffold for regulating neurotransmitter release at the active zone. | 4.71e-06 | 2 | 76 | 2 | 11797009 | |
| Pubmed | Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3. | 4.71e-06 | 2 | 76 | 2 | 26049024 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 7635187 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 24026422 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17015854 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 35613050 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 14550562 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 23770256 | ||
| Pubmed | Membrane bridging by Munc13-1 is crucial for neurotransmitter release. | 4.71e-06 | 2 | 76 | 2 | 30816091 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 19225208 | ||
| Pubmed | Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. | 4.71e-06 | 2 | 76 | 2 | 16706838 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 21789999 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 23761887 | ||
| Pubmed | Munc13-independent vesicle priming at mouse photoreceptor ribbon synapses. | 4.71e-06 | 2 | 76 | 2 | 22674279 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 14981074 | ||
| Pubmed | CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum. | 4.71e-06 | 2 | 76 | 2 | 25292336 | |
| Pubmed | A common molecular basis for membrane docking and functional priming of synaptic vesicles. | 4.71e-06 | 2 | 76 | 2 | 19558619 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 18701688 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17526649 | ||
| Pubmed | Mechanisms Responsible for ω-Pore Currents in Cav Calcium Channel Voltage-Sensing Domains. | 4.71e-06 | 2 | 76 | 2 | 28978442 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 12606379 | ||
| Pubmed | Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators. | 4.71e-06 | 2 | 76 | 2 | 24941892 | |
| Pubmed | Calcium-Independent Exo-endocytosis Coupling at Small Central Synapses. | 4.71e-06 | 2 | 76 | 2 | 31851910 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 24848473 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 22826131 | ||
| Pubmed | Differential control of vesicle priming and short-term plasticity by Munc13 isoforms. | 4.71e-06 | 2 | 76 | 2 | 11832228 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 14985349 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 24470632 | ||
| Pubmed | Munc13 controls the location and efficiency of dense-core vesicle release in neurons. | 4.71e-06 | 2 | 76 | 2 | 23229896 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 11792326 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 24760982 | ||
| Pubmed | Calcium handling precedes cardiac differentiation to initiate the first heartbeat. | 6.67e-06 | 17 | 76 | 3 | 27725084 | |
| Pubmed | Sorcin associates with the pore-forming subunit of voltage-dependent L-type Ca2+ channels. | 1.41e-05 | 3 | 76 | 2 | 9668070 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 19351867 | ||
| Pubmed | Munc13- and SNAP25-dependent molecular bridges play a key role in synaptic vesicle priming. | 1.41e-05 | 3 | 76 | 2 | 37343100 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 18403125 | ||
| Pubmed | Truncation of murine CaV1.2 at Asp-1904 results in heart failure after birth. | 1.41e-05 | 3 | 76 | 2 | 21832054 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 18434746 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D AATF TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.26e-17 | 149 | 76 | 12 | chr17q12 |
| Cytoband | 17q12 | 1.67e-08 | 99 | 76 | 6 | 17q12 | |
| Cytoband | 3q26.1 | 9.94e-04 | 28 | 76 | 2 | 3q26.1 | |
| GeneFamily | UNC13 homologs | 5.75e-08 | 4 | 45 | 3 | 836 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.81e-05 | 3 | 45 | 2 | 287 | |
| GeneFamily | Calcium voltage-gated channel subunits | 3.60e-05 | 26 | 45 | 3 | 253 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.59e-11 | 90 | 74 | 9 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TRPA1 TBC1D3H TBC1D3L SLC35F3 TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.92e-10 | 213 | 74 | 11 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TRPA1 TBC1D3H TBC1D3L SLC35F3 TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.92e-10 | 213 | 74 | 11 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TRPA1 TBC1D3H TBC1D3L SLC35F3 TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 7.46e-10 | 242 | 74 | 11 | PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D FHOD1 TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 4.78e-08 | 281 | 74 | 10 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D FHOD1 TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 4.78e-08 | 281 | 74 | 10 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.68e-06 | 320 | 74 | 9 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TRPA1 TBC1D3H TBC1D3L SLC35F3 TBC1D3D PCNX4 XPA TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.58e-04 | 1153 | 74 | 13 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.17e-07 | 187 | 76 | 6 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 8.43e-07 | 188 | 76 | 6 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-06 | 196 | 76 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-06 | 198 | 76 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-06 | 198 | 76 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-06 | 198 | 76 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.21e-06 | 200 | 76 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 193 | 76 | 5 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 193 | 76 | 5 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 193 | 76 | 5 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.04e-05 | 194 | 76 | 5 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.09e-05 | 195 | 76 | 5 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 195 | 76 | 5 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.25e-05 | 198 | 76 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.25e-05 | 198 | 76 | 5 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.91e-05 | 137 | 76 | 4 | 4dcb15de821439011df1bb0bbd7682d674bd725d | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.91e-05 | 137 | 76 | 4 | c05ceeb7b483324604cb3f647d2da2b3786071b1 | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-04 | 154 | 76 | 4 | 43735f7c58cac51855ded486ee8d8729a1b9909e | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-04 | 154 | 76 | 4 | d55fb73461885e1e02061a344ff89624ef4de487 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 157 | 76 | 4 | d8e283414a770f05d71f0455d0822e9a9660b115 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 157 | 76 | 4 | 165e98bf944572cafbc06ef43c9eab7bd6bea1c2 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 1.58e-04 | 159 | 76 | 4 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.66e-04 | 161 | 76 | 4 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.74e-04 | 163 | 76 | 4 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 1.78e-04 | 164 | 76 | 4 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-04 | 171 | 76 | 4 | 4ccd88cf812dd8bfdc55159c6f504e9c84e4f4fc | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.18e-04 | 173 | 76 | 4 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 2.18e-04 | 173 | 76 | 4 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | ASK428-Immune-B_cell|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.23e-04 | 174 | 76 | 4 | b5a7a612a515736cf3489afd0f6ad2054d54526f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.23e-04 | 174 | 76 | 4 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-04 | 176 | 76 | 4 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.38e-04 | 177 | 76 | 4 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | -Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 2.49e-04 | 179 | 76 | 4 | e4224b2e9c4ae7da62cf670adf811f4112c7d060 | |
| ToppCell | LPS-IL1RA-Myeloid-Neutrophils-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.54e-04 | 180 | 76 | 4 | c0c07937839652e01df10cc1e70aa005800ea6f6 | |
| ToppCell | LPS-IL1RA-Myeloid-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.54e-04 | 180 | 76 | 4 | 079c199425dd3c220f03c6dca1823946f07580a1 | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.59e-04 | 181 | 76 | 4 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.65e-04 | 182 | 76 | 4 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | LPS-IL1RA-Myeloid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.82e-04 | 185 | 76 | 4 | 9b5fd87ea9d05e051ff1251578ecfbe5e8652853 | |
| ToppCell | droplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-04 | 186 | 76 | 4 | 26f1e9930adf2fe4af0819e56f69915bd8330e4a | |
| ToppCell | COVID-19_Convalescent-PLT_4|World / Disease Group and Platelet Clusters | 2.88e-04 | 186 | 76 | 4 | 5954a1e3ffafb33f2a9bc87af3343f304fda4c92 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-04 | 186 | 76 | 4 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.94e-04 | 187 | 76 | 4 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.94e-04 | 187 | 76 | 4 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.00e-04 | 188 | 76 | 4 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.06e-04 | 189 | 76 | 4 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 189 | 76 | 4 | 851f8144aed5c7f80302911cd6b03f14bde7b56d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 189 | 76 | 4 | 3e8e30160a8d6f531ff743cb5918c9e79481f1bd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 190 | 76 | 4 | 1c5cf933ce71fed5638b9ef31eb81f6c2b6dadbc | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 3.12e-04 | 190 | 76 | 4 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.12e-04 | 190 | 76 | 4 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.18e-04 | 191 | 76 | 4 | 47156e5f1d790707f42f6283104a44b33af613e5 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.18e-04 | 191 | 76 | 4 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.24e-04 | 192 | 76 | 4 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-04 | 193 | 76 | 4 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.31e-04 | 193 | 76 | 4 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-04 | 193 | 76 | 4 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 3.31e-04 | 193 | 76 | 4 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-04 | 193 | 76 | 4 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-04 | 193 | 76 | 4 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.31e-04 | 193 | 76 | 4 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-04 | 193 | 76 | 4 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 3.31e-04 | 193 | 76 | 4 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.31e-04 | 193 | 76 | 4 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.37e-04 | 194 | 76 | 4 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 3.37e-04 | 194 | 76 | 4 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.37e-04 | 194 | 76 | 4 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.37e-04 | 194 | 76 | 4 | 607b5d194ba56efa9b106f10f89368fc103712a0 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.37e-04 | 194 | 76 | 4 | 744fd4580942183a1058717d0c3ac86483e366ed | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.37e-04 | 194 | 76 | 4 | f5367072b259ae170cf0df3d4d871ab41be29d29 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.37e-04 | 194 | 76 | 4 | b04cbd240c59755ef7bdeb17fee3028caef6dedb | |
| ToppCell | Healthy-B_intermediate|Healthy / disease group, cell group and cell class | 3.37e-04 | 194 | 76 | 4 | aabee48bf689367edae2079b4b90d253715f1097 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 3.44e-04 | 195 | 76 | 4 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 3.44e-04 | 195 | 76 | 4 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.44e-04 | 195 | 76 | 4 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | Healthy-B_intermediate|World / disease group, cell group and cell class | 3.44e-04 | 195 | 76 | 4 | 9de79e0bdd9063ae65e5edb89cc3fe6f9a8173bc | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.51e-04 | 196 | 76 | 4 | fe8d3f45a64323947c36b127355d5940eb56c0ca | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.51e-04 | 196 | 76 | 4 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.51e-04 | 196 | 76 | 4 | 526d037bb12d81f1c235c60ddc787fbad0bbad77 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.51e-04 | 196 | 76 | 4 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | critical-Myeloid-Neutrophil|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.58e-04 | 197 | 76 | 4 | f1248781e71e3a158d06e9ec93eb90dc6d48bcb2 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.58e-04 | 197 | 76 | 4 | 3cd1c816bc7a57278b2ef615b69545356ab8f522 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.64e-04 | 198 | 76 | 4 | f261a37dd07976548b897af86df1d1a0dc069889 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 3.64e-04 | 198 | 76 | 4 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.64e-04 | 198 | 76 | 4 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | moderate-Myeloid-Neutrophil|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.64e-04 | 198 | 76 | 4 | a6306dac34af5783f3a734ef1eaa7a0c03267b4f | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.64e-04 | 198 | 76 | 4 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 3.64e-04 | 198 | 76 | 4 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 3.64e-04 | 198 | 76 | 4 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.64e-04 | 198 | 76 | 4 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 3.71e-04 | 199 | 76 | 4 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.71e-04 | 199 | 76 | 4 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.79e-04 | 200 | 76 | 4 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.79e-04 | 200 | 76 | 4 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.79e-04 | 200 | 76 | 4 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.79e-04 | 200 | 76 | 4 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.79e-04 | 200 | 76 | 4 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.79e-04 | 200 | 76 | 4 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.79e-04 | 200 | 76 | 4 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.79e-04 | 200 | 76 | 4 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.79e-04 | 200 | 76 | 4 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| Drug | CNS 1145 | 6.44e-10 | 33 | 69 | 6 | CID000190902 | |
| Drug | IHC-64 | 6.44e-10 | 33 | 69 | 6 | CID000162753 | |
| Drug | FPL 64176 | 6.47e-10 | 15 | 69 | 5 | CID000003423 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 4.19e-09 | 79 | 69 | 7 | CID005287890 | |
| Drug | Cinildipine | 1.79e-08 | 56 | 69 | 6 | CID000002752 | |
| Drug | nilvadipine | 2.73e-08 | 60 | 69 | 6 | CID000004494 | |
| Drug | IAA-94 | 3.02e-08 | 61 | 69 | 6 | CID000003667 | |
| Drug | lercanidipine | 3.68e-08 | 63 | 69 | 6 | CID000065866 | |
| Drug | gallopamil | 5.35e-08 | 67 | 69 | 6 | CID000001234 | |
| Drug | AC1L2AC7 | 6.40e-08 | 69 | 69 | 6 | CID000068733 | |
| Drug | CAS 298-57-7 | 9.00e-08 | 73 | 69 | 6 | CID000002761 | |
| Drug | ethosuximide | 9.77e-08 | 74 | 69 | 6 | CID000003291 | |
| Drug | nisoldipine | 1.34e-07 | 78 | 69 | 6 | CID000004499 | |
| Drug | lanthanum | 1.84e-07 | 136 | 69 | 7 | CID000023926 | |
| Drug | methylcoumarin | 2.29e-07 | 18 | 69 | 4 | CID000007092 | |
| Drug | Nilvadipine | 2.65e-07 | 5 | 69 | 3 | DB06712 | |
| Drug | Nisoldipine | 2.65e-07 | 5 | 69 | 3 | DB00401 | |
| Drug | manidipine | 4.36e-07 | 95 | 69 | 6 | CID000004008 | |
| Drug | isotetrandrine | 4.94e-07 | 97 | 69 | 6 | CID000005422 | |
| Drug | nitrendipine | 5.25e-07 | 98 | 69 | 6 | CID000004507 | |
| Drug | chloro-m-cresol | 5.29e-07 | 6 | 69 | 3 | CID000012008 | |
| Drug | CPU-23 | 5.29e-07 | 6 | 69 | 3 | CID003036051 | |
| Drug | NSC114784 | 5.29e-07 | 6 | 69 | 3 | CID000419425 | |
| Drug | isradipine | 5.91e-07 | 100 | 69 | 6 | CID000003784 | |
| Drug | loperamide | 7.89e-07 | 105 | 69 | 6 | CID000003954 | |
| Drug | lavendustin A | 8.69e-07 | 171 | 69 | 7 | CID000003894 | |
| Drug | Amlodipine | 9.24e-07 | 7 | 69 | 3 | DB00381 | |
| Drug | Isradipine | 9.24e-07 | 7 | 69 | 3 | DB00270 | |
| Drug | lamotrigine | 1.42e-06 | 116 | 69 | 6 | CID000003878 | |
| Drug | Nifedipine | 1.48e-06 | 8 | 69 | 3 | DB01115 | |
| Drug | Nitrendipine | 1.48e-06 | 8 | 69 | 3 | DB01054 | |
| Drug | AC1NBU2S | 1.49e-06 | 117 | 69 | 6 | CID004473765 | |
| Drug | fluo-3 | 1.90e-06 | 122 | 69 | 6 | CID000104978 | |
| Drug | dihydropyridine | 1.95e-06 | 193 | 69 | 7 | CID000104822 | |
| Drug | Cinnarizine | 2.21e-06 | 9 | 69 | 3 | DB00568 | |
| Drug | Nimodipine | 2.21e-06 | 9 | 69 | 3 | DB00393 | |
| Drug | bepridil | 2.30e-06 | 126 | 69 | 6 | CID000002351 | |
| Drug | gadolinium | 2.39e-06 | 199 | 69 | 7 | CID000023982 | |
| Drug | pimozide | 2.41e-06 | 127 | 69 | 6 | CID000016362 | |
| Drug | Mibefradil | 4.32e-06 | 11 | 69 | 3 | DB01388 | |
| Drug | Felodipine | 4.32e-06 | 11 | 69 | 3 | DB01023 | |
| Drug | Dantrolene-13C3 | 5.18e-06 | 145 | 69 | 6 | CID000002951 | |
| Drug | nimodipine | 5.18e-06 | 145 | 69 | 6 | CID000004497 | |
| Drug | nicardipine | 5.18e-06 | 145 | 69 | 6 | CID000004473 | |
| Drug | Bay K 8644 | 6.30e-06 | 150 | 69 | 6 | CID000002303 | |
| Drug | procaine | 7.06e-06 | 153 | 69 | 6 | CID000004914 | |
| Drug | AC1L1JG6 | 9.47e-06 | 14 | 69 | 3 | CID000005026 | |
| Drug | gabapentin | 1.25e-05 | 169 | 69 | 6 | CID000003446 | |
| Drug | felodipine | 1.25e-05 | 169 | 69 | 6 | CID000003333 | |
| Drug | Verapamil | 1.45e-05 | 16 | 69 | 3 | DB00661 | |
| Drug | riluzole | 1.47e-05 | 174 | 69 | 6 | CID000005070 | |
| Drug | AC1L9KQO | 1.48e-05 | 49 | 69 | 4 | CID000447335 | |
| Drug | papaverine | 1.57e-05 | 176 | 69 | 6 | CID000004680 | |
| Drug | NSC7524 | 1.90e-05 | 182 | 69 | 6 | CID000005657 | |
| Drug | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | 2.18e-05 | 54 | 69 | 4 | ctd:C054649 | |
| Drug | cobalt-60 | 2.32e-05 | 390 | 69 | 8 | CID000061492 | |
| Drug | baclofen | 2.49e-05 | 191 | 69 | 6 | CID000002284 | |
| Drug | NSC759576 | 2.49e-05 | 191 | 69 | 6 | CID000003075 | |
| Drug | 2-hydroxycarbazole | 2.71e-05 | 3 | 69 | 2 | CID000093551 | |
| Drug | cis-diammineplatinum(II | 2.71e-05 | 3 | 69 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 2.71e-05 | 3 | 69 | 2 | CID002750949 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 2.71e-05 | 3 | 69 | 2 | CID005748312 | |
| Drug | 8N3-cADPR | 2.71e-05 | 3 | 69 | 2 | CID000127713 | |
| Drug | aminodantrolene | 2.71e-05 | 3 | 69 | 2 | CID009570289 | |
| Drug | Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; PC3; HT_HG-U133A | 3.14e-05 | 199 | 69 | 6 | 3759_UP | |
| Drug | succinylcholine | 4.28e-05 | 64 | 69 | 4 | CID000005314 | |
| Drug | mibefradil | 4.28e-05 | 64 | 69 | 4 | CID000060662 | |
| Drug | phenytoin | 5.35e-05 | 219 | 69 | 6 | CID000001775 | |
| Drug | NSC-686960 | 5.41e-05 | 4 | 69 | 2 | CID000192816 | |
| Drug | PCB74 | 5.41e-05 | 4 | 69 | 2 | CID000036218 | |
| Drug | 148504-47-6 | 5.41e-05 | 4 | 69 | 2 | CID006444275 | |
| Drug | SC 38249 | 5.41e-05 | 4 | 69 | 2 | CID000134834 | |
| Drug | AC1L1U7A | 5.41e-05 | 4 | 69 | 2 | CID000035682 | |
| Drug | AC1L1JVU | 6.80e-05 | 72 | 69 | 4 | CID000005229 | |
| Drug | 3-(1H-pyrrole-2-carboxylate | 7.54e-05 | 233 | 69 | 6 | CID000005114 | |
| Drug | B 874-67 | 9.00e-05 | 5 | 69 | 2 | CID000195466 | |
| Drug | methyl beta-aminocrotonate | 9.00e-05 | 5 | 69 | 2 | CID000084253 | |
| Drug | nemadipine-A | 9.00e-05 | 5 | 69 | 2 | CID002856102 | |
| Drug | Fura-2AM | 9.78e-05 | 79 | 69 | 4 | CID000105091 | |
| Drug | lindane | 1.05e-04 | 154 | 69 | 5 | CID000000727 | |
| Drug | M-HN | 1.13e-04 | 31 | 69 | 3 | CID000015450 | |
| Drug | verapamil | 1.15e-04 | 490 | 69 | 8 | CID000002520 | |
| Drug | remifentanil | 1.24e-04 | 32 | 69 | 3 | CID000060814 | |
| Drug | MBED | 1.35e-04 | 6 | 69 | 2 | CID000129958 | |
| Drug | AC1O528X | 1.35e-04 | 6 | 69 | 2 | CID006475857 | |
| Drug | Magnesium Sulfate | 1.35e-04 | 6 | 69 | 2 | DB00653 | |
| Drug | valproate | 1.54e-04 | 381 | 69 | 7 | CID000003121 | |
| Drug | N-methyl-DL-aspartic acid | 1.55e-04 | 655 | 69 | 9 | CID000004376 | |
| Drug | AC1NUZ8M | 1.77e-04 | 92 | 69 | 4 | CID000073211 | |
| Drug | Azumoleno | 1.88e-04 | 7 | 69 | 2 | CID000056259 | |
| Drug | Br2BAPTA | 1.88e-04 | 7 | 69 | 2 | CID003081001 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 1.88e-04 | 7 | 69 | 2 | CID009547999 | |
| Drug | mag-fura-2 | 1.92e-04 | 37 | 69 | 3 | CID000123839 | |
| Drug | U46619 | 2.26e-04 | 285 | 69 | 6 | CID000005618 | |
| Drug | indo-1 | 2.34e-04 | 99 | 69 | 4 | CID000105060 | |
| Drug | dipyrone | 2.43e-04 | 40 | 69 | 3 | CID000003110 | |
| Drug | 1,5-benzothiazepin-4(5H)-one | 2.50e-04 | 8 | 69 | 2 | CID000358939 | |
| Drug | nickel | 2.59e-04 | 552 | 69 | 8 | CID000000934 | |
| Drug | AC1L1DXE | 2.92e-04 | 299 | 69 | 6 | CID000002548 | |
| Drug | pyraclofos | 3.04e-04 | 106 | 69 | 4 | CID000093460 | |
| Disease | Timothy syndrome (implicated_via_orthology) | 3.70e-08 | 4 | 63 | 3 | DOID:0060173 (implicated_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.83e-06 | 195 | 63 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.34e-05 | 3 | 63 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.34e-05 | 3 | 63 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 2.62e-05 | 163 | 63 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 6.30e-05 | 36 | 63 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | macrophage inflammatory protein 1b measurement | 2.08e-04 | 136 | 63 | 4 | EFO_0008219 | |
| Disease | Manic Disorder | 4.78e-04 | 71 | 63 | 3 | C0024713 | |
| Disease | Bipolar Disorder | 5.39e-04 | 477 | 63 | 6 | C0005586 | |
| Disease | Manic | 6.30e-04 | 78 | 63 | 3 | C0338831 | |
| Disease | Depression, Bipolar | 6.53e-04 | 79 | 63 | 3 | C0005587 | |
| Disease | CCL4 measurement | 8.32e-04 | 20 | 63 | 2 | EFO_0004751 | |
| Disease | trans fatty acid measurement, trans/trans-18:2 fatty acid measurement | 1.20e-03 | 24 | 63 | 2 | EFO_0006821, EFO_0006826 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CEKTVLKRVLKELWK | 1366 | Q9UPW8 | |
| RKWACRKKTSVKRKT | 801 | A0FGR9 | |
| RWKVAAAKKLVRTVV | 831 | Q96L91 | |
| KVRFLKLKKERKSLW | 851 | Q8IUA7 | |
| IKRHKWSVLKSRKLA | 306 | P08574 | |
| VTLKTIKKKQKHRIW | 341 | Q9ULW6 | |
| IKKKQKHRIWGTIRT | 346 | Q9ULW6 | |
| LEKKWTSVIRLQKKV | 51 | P43034 | |
| RKEYVTVKIRKKWNS | 911 | Q96NW4 | |
| EVKSAIRKLWRKKVT | 291 | Q96R67 | |
| KCWKRSTKEIVAIKI | 206 | Q86Z02 | |
| RAKTVLTVIKWKGEK | 516 | Q9NPH3 | |
| KKKGWRRSSLVITTK | 156 | Q14722 | |
| RSVLKDWRKVKKLKQ | 1696 | Q15652 | |
| TVLLTSWTEKKQRRK | 546 | Q63HM2 | |
| DTALTRRWVTKKIKV | 111 | Q8NEN9 | |
| IAKVIWCLHTKNKKR | 741 | Q9H7Z3 | |
| RKVQRETARKSQWKK | 1026 | P54098 | |
| IIWLARRLKKGKKSK | 351 | P14151 | |
| KLLRKRSQVWKPKVI | 311 | Q8IVH4 | |
| PHRKTWRKSKKTVKV | 6 | Q96KD3 | |
| KRAKKLLRSWQKLIE | 71 | O95402 | |
| KKDKRVTRRWRTKSV | 306 | Q9BZF3 | |
| VKLLVWQKSVHKLRK | 56 | Q5T319 | |
| EIKSSLRKLIWVRKI | 296 | P47890 | |
| RRTKTVKKILEPKWN | 796 | Q86UR5 | |
| SWAKKIAVKRALKSE | 1056 | A2PYH4 | |
| KDRTLLKTIIKVWKE | 501 | Q9P2K1 | |
| LKTIIKVWKEMKSLR | 506 | Q9P2K1 | |
| AKWKKAVRVTTLMKR | 311 | Q8NCB2 | |
| EELRAIIKKIWKRTS | 1631 | Q13936 | |
| RAIIKKIWKRTSMKL | 1491 | Q13698 | |
| IERRRTVKAAWKIEK | 261 | Q8NCU4 | |
| NTVLWVTIRKELKRK | 306 | P12314 | |
| EWKPTKLVKVSRKNI | 1071 | Q2VIQ3 | |
| KGVICHKRRTSKWKK | 3566 | Q8NDH2 | |
| PTKRKTVKLFWRELK | 621 | Q9Y613 | |
| KEILLKQKTWHIKAR | 136 | Q9C0D2 | |
| RSKKAVWHKLLSKQR | 3581 | Q92736 | |
| QKWLGKETTIKRKIV | 96 | Q0Z7S8 | |
| EELRAVIKKIWKKTS | 1571 | Q01668 | |
| SLVKIFLETRKSWRK | 536 | Q96S52 | |
| REVWRVKFTLAKIRK | 41 | P46781 | |
| KWVESIAKIIRRKKQ | 726 | Q07890 | |
| CQLIEVKKRKKVLSW | 46 | Q8N103 | |
| KDVKKALIKVWGRKT | 346 | Q8NGC0 | |
| ALRKELKTWKVDVVL | 101 | Q8IY81 | |
| WRTKLRRYVAKKLKE | 311 | Q8IY81 | |
| KQIRREISRKSKWVD | 66 | B9A6J9 | |
| IFRLKKTWLKVSKQT | 1141 | Q13972 | |
| WLIKLLTRLKVRKKE | 381 | Q8IY50 | |
| WLAIQKLRSKIHKKV | 491 | Q9NY61 | |
| KIKTFLSLVWKRRIL | 311 | Q5BKT4 | |
| KQIRREISRKSKWVD | 66 | A6NDS4 | |
| KQIRREISRKSKWVD | 66 | P0C7X1 | |
| KRKEVVLTIIRSKRW | 591 | O75762 | |
| LRKLRKWKKSQECVS | 181 | Q8NB66 | |
| KQIRREISRKSKWVD | 66 | A6NER0 | |
| KKAVWHKLLSKQRKR | 3471 | Q15413 | |
| KKKILVTGWERAITV | 246 | Q8IV35 | |
| VIRIKKGVAWTKLKV | 1001 | Q9UQD0 | |
| RQKKISWLKERVKAF | 406 | Q96SB8 | |
| KTVLKRVLKELWRVV | 1286 | O14795 | |
| KQIRREISRKSKWVD | 66 | A0A087X179 | |
| RKVKNKRVRVVWESI | 111 | Q147U7 | |
| IISREKKKIKWIGLT | 176 | Q5H9I0 | |
| LVKHKLIAWERTKTV | 56 | Q9BVS4 | |
| KKVKELRRAVRSSVW | 221 | P23025 | |
| VAKKTKDVTVWRKPS | 31 | Q96DR4 | |
| KQIRREISRKSKWVD | 66 | A0A087WVF3 | |
| TKKIKKLEKETIIWR | 386 | Q9NUQ3 | |
| KQIRREISRKSKWVD | 66 | Q6DHY5 | |
| KQIRREISRKSKWVD | 66 | Q8IZP1 | |
| DIKLTVWKRLFRKVL | 276 | Q86XT4 | |
| KQIRREISRKSKWVD | 66 | A0A087X1G2 | |
| SRKESWKVKSEIPKV | 446 | Q6P2D8 | |
| RVKKTWTVVDAKTLK | 271 | P13010 | |
| KQIRREISRKSKWVD | 66 | A0A087WXS9 | |
| KQIRREISRKSKWVD | 66 | Q6IPX1 |